Source: mdi Blog

mdi Blog FDA Reinstates OMUFA Facility Fees as of 2025

FDA Update No More Free Rides As FDA Reinstates OMUFA Facility Fees as of 2025 FDA is reminding companies who registered with the agency solely to manufacture hand sanitizer during the COVID-19 public health emergency that they are subject to fiscal year (FY) 2025 OMUFA facility fees, unless they delist and deregister before 12 a.m. The post FDA Reinstates OMUFA Facility Fees as of 2025 appeared first on mdi Consultants.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
500-1.0K
Anand Akerkar's photo - President & CEO of mdi

President & CEO

Anand Akerkar

CEO Approval Rating

87/100

Read more